| Autor: |
Akakpo AS; Service dermatologie du CHU Campus, Université de Lomé, BP 81056 Lomé, Togo., Teclessou JN; Service de dermatologie du CHU Campus, Université de Lomé, Togo., Mouhari-Touré A; Service de dermatologie du CHU Kara, Université de Kara, Togo., Saka B; Service dermatologie du CHU Campus, Université de Lomé, BP 81056 Lomé, Togo., Matakloe H; Service de dermatologie du CHU Campus, Université de Lomé, Togo., Kakpovi K; Service de rhumatologie du CHU Sylvanus Olympio, Université de Lomé, Togo., Kombate K; Service de dermatologie du CHU Campus, Université de Lomé, Togo., Pitché P; Service dermatologie du CHU Campus, Université de Lomé, BP 81056 Lomé, Togo. |
| Abstrakt: |
The aim of this study was to document the epidemiological and clinical profile, treatment used, and outcome of patients with scleroderma in hospital settings in Lomé. This descriptive study examined the records of all patients seen as outpatients or admitted for scleroderma in hospital dermatology and rheumatology departments in Lomé during the 20-year period of 1993-2012. During the study period, 50 (0.04%) of the 121,021 patients seen in these departments had scleroderma. There were 29 cases of localized scleroderma and 21 systemic cases, predominantly women (sex-ratio=0.2). The patients' mean age was 36 years. All patients with systemic scleroderma had speckled achromia (100%), and most (90.48%) had cutaneous sclerosis. After a mean follow-up period of 43.5 days, 71.43% of the patients had been lost to follow-up. All of the patients with localized scleroderma had cutaneous sclerosis, and the rate of loss to follow-up (after a mean of 17 days) was 96.55%. The results of this study confirm the extreme rarity of scleroderma in the teaching hospitals in Lomé and a clear female predominance. It points out the difficulty of management, which both influences and is aggravated by the high rate of loss to follow-up. |
